COVID-19大流行对瑞士重症监护病房血培养阳性流行病学的影响:一项全国监测研究
该研究基于瑞士全国监测系统(ANRESIS),分析2020年3月30日至2021年5月31日14个月内52个ICU中ICU患者阳性血培养的前瞻性数据,以瑞士联邦公共卫生办公室提供的ICU患者日数为分母计算血培养污染和ICU血流感染(ICU-BSI)发生率,并用分段泊松回归模型比较间歇期与第二波的发生率比。共识别1099例血培养污染和1616例ICU-BSI。大流行波期间血培养污染和ICU-BSI例数均多于间歇期(2020年夏季)。在更具代表性的第二波(对比间歇期),血培养污染发生率升高(IRR 1.57,95%CI 1.16-2.12),ICU-BSI发生率升高(IRR 1.20,95%CI 1.03-1.39)。血培养污染和ICU-BSI的比例与ICU occupancy rate正相关,而后者在COVID-19波期间更高。
要点
- 第二波(对比间歇期)血培养污染发生率升高(IRR 1.57,95%CI 1.16-2.12),ICU-BSI发生率升高(IRR 1.20,95%CI 1.03-1.39)。
- 研究期间52个ICU共识别1099例血培养污染和1616例ICU-BSI。
- 大流行波期间血培养污染和ICU-BSI例数均多于2020年夏季间歇期。
- 血培养污染和ICU-BSI的比例与ICU occupancy rate正相关,后者在COVID-19波期间更高。
- 第二波疫情期间ICU负担高的月份,血培养污染和ICU-BSI增加尤其明显。
适用人群与场景
- 瑞士52个ICU中ICU患者的阳性血培养,数据通过全国监测系统(ANRESIS)前瞻性收集,时间为2020年3月30日至2021年5月31日,共14个月。
研究设计与关键结果
- 研究类型:基于全国监测系统(ANRESIS)的前瞻性数据、全国性监测研究,分析2020年3月30日至2021年5月31日14个月内52个ICU中ICU患者阳性血培养。
- 共识别1099例血培养污染和1616例ICU-BSI。
- 大流行波期间血培养污染和ICU-BSI例数均多于间歇期(2020年夏季)。
- 第二波(对比间歇期)血培养污染发生率升高(IRR 1.57,95%CI 1.16-2.12)。
- 第二波(对比间歇期)ICU-BSI发生率升高(IRR 1.20,95%CI 1.03-1.39)。
- 血培养污染和ICU-BSI的比例与ICU occupancy rate正相关,后者在COVID-19波期间更高。
证据类型、等级与局限
- 证据类型:基于全国监测系统(ANRESIS)前瞻性收集数据的监测研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论:第二波COVID-19疫情期间观察到血培养污染和ICU-BSI增加,尤其在ICU的COVID-19患者负担高的月份。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Evidence about the impact of the pandemic of COVID-19 on the incidence rates of blood cultures contaminations and bloodstream infections in intensive care units (ICUs) remains scant. The objective of this study was to investigate the nationwide epidemiology of positive blood cultures drawn in ICUs during the first two pandemic waves of COVID-19 in Switzerland.
METHODS: We analyzed data on positive blood cultures among ICU patients, prospectively collected through a nationwide surveillance system (ANRESIS), from March 30, 2020, to May 31, 2021, a 14-month timeframe that included a first wave of COVID-19, which affected the French and Italian-speaking regions, an interim period (summer 2020) and a second wave that affected the entire country. We used the number of ICU patient-days provided by the Swiss Federal Office of Public Health as denominator to calculate incidence rates of blood culture contaminations and bloodstream infections (ICU-BSI). Incidence rate ratios comparing the interim period with the second wave were determined by segmented Poisson regression models.
RESULTS: A total of 1099 blood culture contaminations and 1616 ICU-BSIs were identified in 52 ICUs during the study. Overall, more episodes of blood culture contaminations and ICU-BSI were observed during the pandemic waves, compared to the interim period. The proportions of blood culture contaminations and ICU-BSI were positively associated with the ICU occupancy rate, which was higher during the COVID-19 waves. During the more representative second wave (versus interim period), we observed an increased incidence of blood culture contaminations (IRR 1.57, 95% CI 1.16-2.12) and ICU-BSI (IRR 1.20, 95% CI 1.03-1.39).
CONCLUSIONS: An increase in blood culture contaminations and ICU-BSIs was observed during the second COVID-19 pandemic wave, especially in months when the ICU burden of COVID-19 patients was high.
参考来源
- Damonti L, Kronenberg A, Marschall J, et al. The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Crit Care. 2021. PMID: 34809698. doi:10.1186/s13054-021-03814-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。